The role of neurocognitive functioning, substance use variables and the DSM-5 severity scale in cocaine relapse: A prospective study
Carregando...
Citações na Scopus
13
Tipo de produção
article
Data de publicação
2019
Título da Revista
ISSN da Revista
Título do Volume
Editora
ELSEVIER IRELAND LTD
Autores
SANTOS, Bernardo dos
CAVALLET, Mikael
Citação
DRUG AND ALCOHOL DEPENDENCE, v.197, p.255-261, 2019
Resumo
Background: The severity of substance use disorder (SUD) is currently defined by the sum of DSM-5 criteria. However, little is known about the validity of this framework or the role of additional severity indicators in relapse prediction. This study aimed to investigate the relationship between DSM-5 criteria, neurocognitive functioning, substance use variables and cocaine relapse among inpatients with cocaine use disorder (CUD). Methods: 128 adults aged between 18 and 45 years were evaluated; 68 (59 males, 9 females) had CUD and 60 (52 males, 8 females) were healthy controls. For the group with CUD, the use of other substances was not an exclusion criterion. Participants were tested using a battery of neurocognitive tests. Cocaine relapse was evaluated 3 months after discharge. Results: Scores for attention span and working memory were worse in patients compared to controls. Earlier onset and duration of cocaine use were related to poorer inhibitory control and global executive functioning, respectively; recent use was related to worse performance in inhibitory control, attention span and working memory. More DSM-5 criteria at baseline were significantly associated with relapse. Conclusions: Recent cocaine use was the most predictive variable for neurocognitive impairments, while DSM-5 criteria predicted cocaine relapse at three months post treatment. The integration of neurocognitive measures, DSM-5 criteria and cocaine use variables in CUD diagnosis could improve severity differentiation. Longitudinal studies using additional biomarkers are needed to disentangle the different roles of severity indicators in relapse prediction and to achieve more individualized and effective treatment strategies for these patients.
Palavras-chave
Addiction, Assessment, Cocaine, Neurocognition, Relapse, Severity
Referências
- Adinoff B, 2014, ADDICT BIOL, V19, P250, DOI 10.1111/j.1369-1600.2012.00450.x
- Agrawal A, 2011, ADDICTION, V106, P1935, DOI 10.1111/j.1360-0443.2011.03517.x
- Aharonovich E, 2006, DRUG ALCOHOL DEPEN, V81, P313, DOI 10.1016/j.drugalcdep.2005.08.003
- American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU
- Arbour S, 2011, SUBST USE MISUSE, V46, P1275, DOI 10.3109/10826084.2011.572941
- Bolla KI, 1999, J NEUROPSYCH CLIN N, V11, P361, DOI 10.1176/jnp.11.3.361
- Czapla M, 2016, ADDICT BIOL, V21, P873, DOI 10.1111/adb.12229
- Capella MD, 2015, SCI REP-UK, V5, DOI 10.1038/srep12038
- DeVito EE, 2019, ADDICT BEHAV, V89, P10, DOI 10.1016/j.addbeh.2018.09.005
- Di Sclafani V, 2002, DRUG ALCOHOL DEPEN, V66, P161, DOI 10.1016/S0376-8716(01)00197-1
- Dubois B, 2000, NEUROLOGY, V55, P1621, DOI 10.1212/WNL.55.11.1621
- Faller Sibele, 2014, Trends Psychiatry Psychother., V36, P193, DOI 10.1590/2237-6089-2014-0040
- Fazzino TL, 2014, DRUG ALCOHOL DEPEN, V141, P39, DOI 10.1016/j.drugalcdep.2014.05.004
- Fleury MJ, 2016, DRUG ALCOHOL DEPEN, V168, P293, DOI 10.1016/j.drugalcdep.2016.08.625
- Fontes MA, 2011, BRIT J PSYCHIAT, V198, P442, DOI 10.1192/bjp.bp.110.077479
- Garrison KA, 2014, CURR PSYCHIAT REP, V16, DOI 10.1007/s11920-014-0513-5
- Goncalves PD, 2014, DRUG ALCOHOL DEPEN, V141, P79, DOI 10.1016/j.drugalcdep.2014.05.006
- Grant BF, 1998, J SUBST ABUSE, V10, P163, DOI 10.1016/S0899-3289(99)80131-X
- Hasin DS, 2013, AM J PSYCHIAT, V170, P834, DOI 10.1176/appi.ajp.2013.12060782
- Cunha PJ, 2010, ADDICT BEHAV, V35, P875, DOI 10.1016/j.addbeh.2010.05.005
- Kopak A.M., 2014, CURRENT ADDICTION RE, V1, P166
- Kwako LE, 2016, BIOL PSYCHIAT, V80, P179, DOI 10.1016/j.biopsych.2015.10.024
- Lima DR, 2015, AUST NZ J PSYCHIAT, V49, P940, DOI 10.1177/0004867415589384
- Lopes BM, 2017, ADDICT BEHAV, V73, P41, DOI 10.1016/j.addbeh.2017.04.013
- Lynskey MT, 2003, JAMA-J AM MED ASSOC, V289, P427, DOI 10.1001/jama.289.4.427
- Madoz-Gurpide A, 2011, DRUG ALCOHOL DEPEN, V117, P55, DOI 10.1016/j.drugalcdep.2010.11.030
- Marceau EM, 2017, DRUG ALCOHOL DEPEN, V178, P150, DOI 10.1016/j.drugalcdep.2017.04.023
- Martin CS, 2014, ADDICTION, V109, P1773, DOI 10.1111/add.12615
- McLellan AT, 2006, AM J ADDICTION, V15, P113, DOI 10.1080/10550490500528316
- Moreno-Lopez L, 2015, ADDICT BIOL, V20, P546, DOI 10.1111/adb.12143
- Moreno-Lopez L, 2012, DRUG ALCOHOL DEPEN, V125, P208, DOI 10.1016/j.drugalcdep.2012.02.012
- Pombo S, 2008, ALCOHOL ALCOHOLISM, V43, P423, DOI 10.1093/alcalc/agn021
- Preuss UW, 2014, PSYCHOL MED, V44, P3303, DOI 10.1017/S0033291714000889
- Schulte MHJ, 2014, CLIN PSYCHOL REV, V34, P531, DOI 10.1016/j.cpr.2014.08.002
- SILVERSTEIN AB, 1982, J CONSULT CLIN PSYCH, V50, P415, DOI 10.1037//0022-006X.50.3.415
- SPITZER RL, 1992, ARCH GEN PSYCHIAT, V49, P624
- Stevens L, 2014, J SUBST ABUSE TREAT, V47, P58, DOI 10.1016/j.jsat.2014.01.008
- Streeter CC, 2008, NEUROPSYCHOPHARMACOL, V33, P827, DOI 10.1038/sj.npp.1301465
- Tanabe J, 2009, BIOL PSYCHIAT, V65, P160, DOI 10.1016/j.biopsych.2008.07.030
- Turner TH, 2009, J SUBST ABUSE TREAT, V37, P328, DOI 10.1016/j.jsat.2009.03.009
- Verdejo-Garcia A, 2012, DRUG ALCOHOL DEPEN, V122, P142, DOI 10.1016/j.drugalcdep.2011.09.025
- Verdejo-Garcia A, 2007, DRUG ALCOHOL DEPEN, V90, P2, DOI 10.1016/j.drugalcdep.2007.02.004
- Verdejo-Garcia A, 2007, DRUG ALCOHOL DEPEN, V90, P48, DOI 10.1016/j.drugalcdep.2007.02.010
- Volkow ND, 2016, NEW ENGL J MED, V374, P363, DOI 10.1056/NEJMra1511480
- Vonmoos M, 2014, NEUROPSYCHOPHARMACOL, V39, P2200, DOI 10.1038/npp.2014.71
- Wechsberg WM, 2008, SUBST USE MISUSE, V43, P1277, DOI 10.1080/10826080802215171
- Wechsler D, 1981, WECHSLER ADULT INTEL
- Wechsler D., 1997, WECHSLER MEMORY SCAL
- Weiss LM, 2014, J SUBST ABUSE TREAT, V47, P146, DOI 10.1016/j.jsat.2014.04.003